-
Ayuso happy to fly under radar at Tour de France
-
Iran leaders pay last respects to Khamenei as mourners gather
-
Curran ready to fill England gap left by Stokes exit
-
UN issues 'red alert' over 'catastrophe' in Sudan's El-Obeid
-
Djokovic has history on the line at Wimbledon
-
Tour de France to start with team time-trial 'bang'
-
Hamilton sparkles in Silverstone sunshine
-
Dressed for success: Osaka reaches Wimbledon last 16 for first time
-
Swift and Kelce set to tie the knot in glitzy arena extravaganza
-
Bayern sign Germany defender Brown until 2031
-
Police hunt for Ukrainian woman over Monaco bomb attack
-
MEXC's June Highlights: $437 Billion in Trading Volume, Offering Access to 7,000+ US Stocks and ETFs
-
Kenya's abortion taboo is killing thousands of women
-
Stocks mostly rise as beaten-down tech stocks enjoy bounce
-
Madonna returns to form with dancefloor filler "Confessions II"
-
Iranian leaders pay respects to supreme leader as Tehran prepares for funeral
-
Dean says Australia final a 'fresh start' for England
-
Doubles not a 'carnival sideshow' say players amid schedule row
-
Wimbledon giving Serena 'as much time' as possible for doubles
-
Klopp in 'talks' for Germany job after Nagelsmann exit: federation
-
Chinese investors flock to Hong Kong as trading curbs tighten
-
Surging real estate development divides opinion on Athens' riviera
-
Projected 'super typhoon' heads for US Pacific islands
-
Move over, Messi! Robot footballers thrill crowds in South Korea
-
UN warns of strong looming El Nino
-
France deaths rose by 30% during heatwave
-
Hunt for last signs of life in Venezuela quake zone
-
Drones spot sharks 73 times in two days off Sydney beaches
-
Asian markets rise as beaten-down tech stocks enjoy bounce
-
Supreme leader's body arrives at Tehran religious complex for funeral
-
David v Goliath as Cape Verde face Messi's Argentina at World Cup
-
Mbappe's French juggernaut face Paraguay, eye World Cup quarter-finals
-
Nagelsmann quits as Germany coach after World Cup exit: reports
-
Wallabies riding wave of patriotic support against Ireland
-
All Blacks return to Christchurch 'a blessing', says Savea
-
Belgium opens up Congo archives amid global minerals race
-
'Not a museum': Slovak UNESCO village strains under tourism
-
Wimbledon clings onto fashion traditions, with a twist
-
DR Congo opposition builds against presidential third-term bid
-
Death toll from massive strikes on Kyiv rises to 30
-
China sports brands score NBA stars to assist global ambitions
-
El Nino set to be strong, UN warns
-
Man dies after setting self ablaze outside UN in New York: police
-
'Inspired millions': Modric praised as World Cup career appears at end
-
VAR 'taking joy' from football says Croatia coach Dalic after loss
-
Death toll hits 10 in Thai monk procession crash
-
Afghans come home but risk exclusion without any ID
-
Asian markets rise as beaten tech stocks enjoy respite from selling
-
'Coincidence of life' says Ronaldo after Jota tribute a year from death
-
'Royal wedding': Swift and Kelce kick off star-studded celebrations
Swiss seize window of opportunity on Trump tariffs
Switzerland will once again Friday try to talk its way out of punitive tariffs on its exports to the United States, which would have serious ramifications for Swiss jobs and businesses.
US Treasury Secretary Scott Bessent and China's Vice Premier He Lifeng are meeting in Geneva in an attempt to cool the trade war between the world's two biggest economies.
That has given the Swiss another chance to twist Washington's arm over the global wave of tariffs unleashed by US President Donald Trump on April 2, and comes a day after Britain reached a deal with the United States avoiding the worst of the punitive levies.
Swiss President Karin Keller-Sutter, who is also the country's finance minister, and Economy Minister Guy Parmelin are set to meet Bessent and US Trade Representative Jamieson Greer at a top hotel in Geneva.
Few details have been made public about the talks, but the Swiss were also set to meet Vice Premier He and were due to hold a press conference later on Friday.
Keller-Sutter and Parmelin already met Bessent and Greer in Washington late last month in a bid to negotiate lower tariffs.
- Watchmakers on borrowed time? -
Given the size of Switzerland's trade surplus -- exporting more to the United States than it imports from it -- the Trump administration has threatened to impose a 31 percent levy on Swiss exports to the United States.
This would be catastrophic for major sectors of Switzerland's economy, such as manufacturing and watchmaking.
For now, Washington is imposing a 10 percent levy on goods coming from Switzerland.
In 2024, the total value of Switzerland's goods exports to the United States was expected to reach 52.65 billion Swiss francs ($63.7 billion), with pharmaceutical products being the largest export.
Imports of goods from the United States were valued at 14.13 billion francs, according to Switzerland's Federal Office for Customs and Border Security.
Switzerland is the sixth-largest foreign investor in the United States, and ranks first in research and development, with pharmaceuticals being a key sector.
The United States is Switzerland's biggest trading partner after the European Union.
- Nespresso and big pharma -
There may be only so far that Keller-Sutter can get Washington to bend.
US Commerce Secretary Howard Lutnick said Thursday that Washington was likely to impose tariffs of more than 10 percent on trading partners with which it has a trade deficit.
"The 10 percent baseline is for those countries that have (a) balanced budget with us, that are the best," Lutnick told CNBC television. "Those who had trade deficits are going to have a higher tariff."
The potential repercussions of the Trump tariffs on Switzerland are still difficult to quantify.
When publishing its quarterly sales figures, food giant Nestle indicated that its Swiss-made Nespresso coffee pods were likely to be affected.
Pharmaceuticals were not targeted in the tariffs announced in early April -- though the Trump administration has blown hot and cold on such products since then.
Faced with the uncertainties, two Swiss heavyweights in the sector took their own initiative.
Novartis announced in mid-April that it was increasing its investments in the United States by $23 billion over five years, with Roche announcing shortly afterwards that it likewise planned to invest $50 billion over five years.
C.Koch--VB